What is the management approach for Charcot-Marie-Tooth (CMT) disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth (CMT) disease requires a multidisciplinary supportive care approach focused on rehabilitation, orthotic management, and symptomatic treatment, as no disease-modifying pharmacologic therapies are currently available for clinical use. 1, 2, 3

Diagnostic Evaluation

Early diagnosis is critical to prevent deformity and optimize functional outcomes. 4

  • MRI is the recommended advanced imaging modality for comprehensive assessment of bones, joints, ligaments, and tendons in CMT patients 4
  • Genetic testing should be pursued to identify the specific CMT subtype, as over 80 genes are implicated in these inherited neuropathies 2
  • Clinical assessment should focus on progressive muscular weakness, pes cavus deformity, loss of deep tendon reflexes, distal sensory loss, and gait impairment 5

Orthotic and Rehabilitation Management

Orthotic interventions should be implemented early to prevent progression of deformities. 4

Footwear and Orthotics

  • Custom footwear with specialized insoles must be prescribed to ensure ongoing offloading and prevent skin breakdown 4
  • Below-knee customized devices should be used when deformity and/or joint instability is present to optimize plantar pressure distribution 6

Rehabilitation Protocol

  • Intensive rehabilitation programs (2-4 hours daily, 5 days per week, for 3 weeks) significantly improve short-term muscle strength and functional outcomes in mild to moderate CMT 5
  • The rehabilitation program should include: manual treatments, strengthening exercises, stretching, core stability training, balance and resistance training, aerobic exercises, and tailored self-care training 5
  • Physical and occupational therapy are essential components of long-term management 7

Important Caveat

  • Improvements from intensive rehabilitation are not sustained at 1-year follow-up, suggesting the need for ongoing periodic rehabilitation interventions rather than one-time treatment 5

Symptomatic Management

  • Pain and fatigue management should be addressed as these significantly impact quality of life 7, 2
  • Analgesic medications may be necessary for neuropathic pain 2
  • Mental health support should be integrated into care, as CMT impacts psychological well-being 7

Surgical Considerations

  • Surgical treatment of skeletal deformities (particularly pes cavus) may be necessary when conservative management fails 5, 2
  • Surgery should be considered for progressive deformities that interfere with ambulation or orthotic fitting 2

Multidisciplinary Team Composition

Optimal management requires coordination among: 7

  • Neurologists for diagnosis and ongoing neurologic assessment 7
  • Genetic counselors for family planning and genetic testing interpretation 7
  • Physical and occupational therapists for functional training 7
  • Physiatrists for rehabilitation oversight 7
  • Orthotists for custom bracing and footwear 7
  • Mental health providers for psychological support 7
  • Orthopedic surgeons when surgical intervention is needed 2

Monitoring and Follow-up

  • Regular follow-up according to disease severity is essential to monitor progression and adjust interventions 3
  • Standardized clinical instruments should be used to assess disease progression and disability over time 7
  • Patient-reported outcome measures should guide treatment adjustments 7

Emerging Therapies (Not Yet Available for Clinical Use)

While several investigational approaches are under development, no disease-modifying therapies have been proven effective in humans: 1, 3

  • Gene therapy approaches (gene silencing for PMP22 in CMT1A, gene replacement for recessive forms) remain experimental 1, 3
  • PXT3003 is in phase III trials for CMT1A but not yet approved 1
  • Various molecular targets (neuregulin pathway, HDAC6 inhibitors, UPR modulators) show promise in animal models but lack human efficacy data 1, 3

Critical Pitfalls to Avoid

  • Delayed diagnosis and referral to multidisciplinary care can lead to significant clinical deterioration and irreversible deformities 4
  • Failing to implement early orthotic interventions allows preventable progression of foot deformities 4
  • Treating rehabilitation as a one-time intervention rather than an ongoing periodic need leads to loss of functional gains 5

References

Research

Therapeutic options in Charcot-Marie-Tooth diseases.

Expert review of neurotherapeutics, 2015

Research

Treatment of Charcot-Marie-Tooth neuropathies.

Revue neurologique, 2023

Guideline

Diagnostic Evaluation and Management of Charcot-Marie-Tooth Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Effects of intensive rehabilitation on functioning in patients with mild and moderate Charcot-Marie-Tooth disease: a real-practice retrospective study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.